This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Current Discounted Rates End In:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Norbert Pardi, PhD
Research Assistant Professor of Medicine at University of Pennsylvania

Profile

Dr Norbert Pardi holds a Ph.D. in biochemistry and genetics. He has been working at the University of Pennsylvania since 2011. His research interest is the development of mRNA-based therapeutics with particular focus on new generation vaccines. He explored the development of a novel therapeutic delivery platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective vaccines targeting various pathogens. Dr. Pardi is a pioneer of the nucleoside-modified mRNA vaccine technology and published milestone papers in the field. He is regularly invited to give lectures at prestigious scientific meetings.

Agenda Sessions

  • Development of Broadly Protective Influenza Vaccines Using Nucleoside-modified mRNA

    2:00pm